Park, J. S., Gazzaniga, F. S., Wu, M., Luthens, A. K., Gillis, J., Zheng, W., . . . Sharpe, A. H. (2023). Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance. Nature (London), 617(7960), 377-385. https://doi.org/10.1038/s41586-023-06026-3
Chicago Style (17th ed.) CitationPark, Joon Seok, et al. "Targeting PD-L2–RGMb Overcomes Microbiome-related Immunotherapy Resistance." Nature (London) 617, no. 7960 (2023): 377-385. https://doi.org/10.1038/s41586-023-06026-3.
MLA (9th ed.) CitationPark, Joon Seok, et al. "Targeting PD-L2–RGMb Overcomes Microbiome-related Immunotherapy Resistance." Nature (London), vol. 617, no. 7960, 2023, pp. 377-385, https://doi.org/10.1038/s41586-023-06026-3.
Warning: These citations may not always be 100% accurate.